Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma.

Takahashi S, Uemura M, Kimura T, Kawasaki Y, Takamoto A, Yamaguchi A, Melhem-Bertrandt A, Gartner EM, Inoue T, Akazawa R, Kadokura T, Tanikawa T.

Invest New Drugs. 2019 Aug 14. doi: 10.1007/s10637-019-00844-x. [Epub ahead of print]

PMID:
31444589
2.

Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy.

Rosenberg JE, O'Donnell PH, Balar AV, McGregor BA, Heath EI, Yu EY, Galsky MD, Hahn NM, Gartner EM, Pinelli JM, Liang SY, Melhem-Bertrandt A, Petrylak DP.

J Clin Oncol. 2019 Oct 10;37(29):2592-2600. doi: 10.1200/JCO.19.01140. Epub 2019 Jul 29.

3.

A phase 1 trial of SGN-CD70A in patients with CD70-positive, metastatic renal cell carcinoma.

Pal SK, Forero-Torres A, Thompson JA, Morris JC, Chhabra S, Hoimes CJ, Vogelzang NJ, Boyd T, Bergerot PG, Adashek JJ, Li H, Yu X, Gartner EM, Carret AS, Smith DC.

Cancer. 2019 Apr 1;125(7):1124-1132. doi: 10.1002/cncr.31912. Epub 2019 Jan 9.

PMID:
30624766
4.

A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma.

Phillips T, Barr PM, Park SI, Kolibaba K, Caimi PF, Chhabra S, Kingsley EC, Boyd T, Chen R, Carret AS, Gartner EM, Li H, Yu C, Smith DC.

Invest New Drugs. 2019 Apr;37(2):297-306. doi: 10.1007/s10637-018-0655-0. Epub 2018 Aug 22.

5.

Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer.

Clemens MR, Gladkov OA, Gartner E, Vladimirov V, Crown J, Steinberg J, Jie F, Keating A.

Breast Cancer Res Treat. 2015 Jan;149(1):171-9. doi: 10.1007/s10549-014-3238-6. Epub 2014 Dec 30.

6.

Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic breast cancer.

Tolaney S, Burris H, Gartner E, Mayer IA, Saura C, Maurer M, Ciruelos E, Garcia AA, Campana F, Wu B, Xu Y, Jiang J, Winer E, Krop I.

Breast Cancer Res Treat. 2015 Jan;149(1):151-61. doi: 10.1007/s10549-014-3248-4. Epub 2014 Dec 24.

PMID:
25537644
7.

Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma.

Tannir NM, Forero-Torres A, Ramchandren R, Pal SK, Ansell SM, Infante JR, de Vos S, Hamlin PA, Kim SK, Whiting NC, Gartner EM, Zhao B, Thompson JA.

Invest New Drugs. 2014 Dec;32(6):1246-57. doi: 10.1007/s10637-014-0151-0. Epub 2014 Aug 22.

PMID:
25142258
8.

Dasatinib is synergistic with cetuximab and cisplatin in triple-negative breast cancer cells.

Kim EM, Mueller K, Gartner E, Boerner J.

J Surg Res. 2013 Nov;185(1):231-9. doi: 10.1016/j.jss.2013.06.041. Epub 2013 Jul 17.

PMID:
23899511
9.

A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer.

Gartner EM, Silverman P, Simon M, Flaherty L, Abrams J, Ivy P, Lorusso PM.

Breast Cancer Res Treat. 2012 Feb;131(3):933-7. doi: 10.1007/s10549-011-1866-7. Epub 2011 Nov 15.

10.

Lack of effect of casopitant on the pharmacokinetics of docetaxel in patients with cancer.

Dandamudi UB, Adams LM, Johnson B, Bauman J, Morris S, Murray S, Webb RT, Gartner E, Hohl R, Lewis LD.

Cancer Chemother Pharmacol. 2011 Apr;67(4):783-90. doi: 10.1007/s00280-010-1381-2. Epub 2010 Jun 17.

PMID:
20556613
11.

Tremelimumab in combination with exemestane in patients with advanced breast cancer and treatment-associated modulation of inducible costimulator expression on patient T cells.

Vonderheide RH, LoRusso PM, Khalil M, Gartner EM, Khaira D, Soulieres D, Dorazio P, Trosko JA, Rüter J, Mariani GL, Usari T, Domchek SM.

Clin Cancer Res. 2010 Jul 1;16(13):3485-94. doi: 10.1158/1078-0432.CCR-10-0505. Epub 2010 May 17.

12.

Poly(adp-ribose) polymerase inhibitors: a novel drug class with a promising future.

Gartner EM, Burger AM, Lorusso PM.

Cancer J. 2010 Mar-Apr;16(2):83-90. doi: 10.1097/PPO.0b013e3181d78223. Review.

PMID:
20404603
13.

A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer.

Gartner EM, Griffith KA, Pan Q, Brewer GJ, Henja GF, Merajver SD, Zalupski MM.

Invest New Drugs. 2009 Apr;27(2):159-65. doi: 10.1007/s10637-008-9165-9. Epub 2008 Aug 20.

14.

Daily utility and satisfaction with rollators among persons with chronic obstructive pulmonary disease.

Hill K, Goldstein R, Gartner EJ, Brooks D.

Arch Phys Med Rehabil. 2008 Jun;89(6):1108-13. doi: 10.1016/j.apmr.2007.11.032.

PMID:
18503807
15.

In vivo assessment of the efficacy of an innovative face care system in subjects with mild acne vulgaris.

Scherdin U, Presto S, Rippke F, Nielsen J, Strassner M, Imadojemun A, Gärtner E, Herpens A, Korting HC, Bielfeldt S.

Int J Cosmet Sci. 2004 Oct;26(5):221-9. doi: 10.1111/j.1467-2494.2004.00225.x.

PMID:
18492134
16.

The Supreme Court and the Partial-birth Abortion Ban Act of 2003: a political procedure replaces woman-centered care.

Gartner EC.

MedGenMed. 2007;9(3):41; author reply 41. No abstract available.

PMID:
18159623
17.

Rhizobium-initiated rice growth inhibition caused by nitric oxide accumulation.

Perrine-Walker FM, Gartner E, Hocart CH, Becker A, Rolfe BG.

Mol Plant Microbe Interact. 2007 Mar;20(3):283-92.

18.

Distribution of sunscreens on skin.

Schulz J, Hohenberg H, Pflücker F, Gärtner E, Will T, Pfeiffer S, Wepf R, Wendel V, Gers-Barlag H, Wittern KP.

Adv Drug Deliv Rev. 2002 Nov 1;54 Suppl 1:S157-63. Review.

PMID:
12460721
19.

The human stratum corneum layer: an effective barrier against dermal uptake of different forms of topically applied micronised titanium dioxide.

Pflücker F, Wendel V, Hohenberg H, Gärtner E, Will T, Pfeiffer S, Wepf R, Gers-Barlag H.

Skin Pharmacol Appl Skin Physiol. 2001;14 Suppl 1:92-7.

PMID:
11509913
20.
21.

Absence of TP53 alterations in pheochromocytomas and medullary thyroid carcinomas.

Herfarth KK, Wick MR, Marshall HN, Gartner E, Lum S, Moley JF.

Genes Chromosomes Cancer. 1997 Sep;20(1):24-9.

PMID:
9290950
22.

Three different actions of phenylglyoxal on band 3 protein-mediated anion transport across the red blood cell membrane.

Gärtner EM, Liebold K, Legrum B, Fasold H, Passow H.

Biochim Biophys Acta. 1997 Jan 31;1323(2):208-22.

23.

Transport-related conformational states of the band 3 protein: probing with 1-fluoro-2,4-dinitrobenzene.

Ruffing W, Gärtner EM, Lepke S, Legrum B, Passow H.

Cell Mol Biol (Noisy-le-grand). 1996 Nov;42(7):1097-118.

PMID:
8960782
24.

Transgenic white clover. Studies with the auxin-responsive promoter, GH3, in root gravitropism and lateral root development.

Larkin PJ, Gibson JM, Mathesius U, Weinman JJ, Gartner E, Hall E, Tanner GJ, Rolfe BG, Djordjevic MA.

Transgenic Res. 1996 Sep;5(5):325-35.

PMID:
11539555
25.

High-copy expression vector based on amplification-promoting sequences.

Hemann C, Gärtner E, Weidle UH, Grummt F.

DNA Cell Biol. 1994 Apr;13(4):437-45.

PMID:
8011170
26.

Assay of D-dimer based on immunofiltration and staining with gold colloids.

Gogstad GO, Dale S, Brosstad F, Brandsnes O, Holtlund J, Mørk E, Gärtner E, Borch SM.

Clin Chem. 1993 Oct;39(10):2070-6.

27.
28.

Construction of an Acid-Tolerant Rhizobium leguminosarum Biovar Trifolii Strain with Enhanced Capacity for Nitrogen Fixation.

Chen H, Richardson AE, Gartner E, Djordjevic MA, Roughley RJ, Rolfe BG.

Appl Environ Microbiol. 1991 Jul;57(7):2005-11.

29.

[Megestrol acetate versus medroxyprogesterone acetate in the treatment of metastasizing breast cancers. Intermediate report of a multicenter phase III study].

Wander HE, Kleeberg UR, Gärtner E, Hartlapp J, Scherpe A, Bönisch E, Nagel GA.

Onkologie. 1987 Apr;10(2):104-6. German. No abstract available.

PMID:
2954006
30.

Anion transport across the red blood cell membrane and the conformation of the protein in Band 3.

Passow H, Fasold H, Gärtner EM, Legrum B, Ruffing W, Zaki L.

Ann N Y Acad Sci. 1980;341:361-83. Review.

PMID:
6772068
31.

Fate of polychlorinated biphenyl (Aroclor 1242) in an experimental study and its significance to the natural environment.

Gresshoff PM, Mahanty HK, Gärtner E.

Bull Environ Contam Toxicol. 1977 Jun;17(6):686-91. No abstract available.

PMID:
406951
32.

[The influence of chloramphenicol treatment of drinking water on the staphylococcal flora of the air of a laying hen battery].

Müller W, Gärtner E, Kiefer H.

Berl Munch Tierarztl Wochenschr. 1976 Jun 15;89(12):240-43. German. No abstract available.

PMID:
938448
33.

[Blood circulation, oxygen pressure and pH of the cerebral cortex under the influence of bencyclane].

Gärtner E, Enzenross HG, Vlahov V, Schanzenbächer P, Brandt H, Betz E.

Arzneimittelforschung. 1975 Jun;25(6):887-91. German.

PMID:
240368
34.

[Increase of the dose in primary irradiation of breast carcinoma].

Gärtner E.

Rontgenblatter. 1973 Feb;26(2):73-9. German. No abstract available.

PMID:
4710152
35.

Energy-rich metabolites and EEG in hypoxia and in hypercapnia.

Schindler U, Gärtner E, Betz E.

Adv Exp Med Biol. 1973;37A:233-8. No abstract available.

PMID:
4500032

Supplemental Content

Loading ...
Support Center